Capital Fund Management S.A. raised its stake in Amsurg Corp. (NASDAQ:AMSG) by 42.9% during the second quarter, Holdings Channel reports. The fund owned 9,634 shares of the company’s stock after buying an additional 2,893 shares during the period. Capital Fund Management S.A.’s holdings in Amsurg Corp. were worth $747,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Raymond James Trust N.A. increased its position in shares of Amsurg Corp. by 4.6% in the second quarter. Raymond James Trust N.A. now owns 5,042 shares of the company’s stock valued at $391,000 after buying an additional 223 shares during the last quarter. Mount Lucas Management LP increased its position in shares of Amsurg Corp. by 10.3% in the first quarter. Mount Lucas Management LP now owns 3,483 shares of the company’s stock valued at $260,000 after buying an additional 326 shares during the last quarter. Retirement Systems of Alabama increased its position in shares of Amsurg Corp. by 1.0% in the second quarter. Retirement Systems of Alabama now owns 69,743 shares of the company’s stock valued at $5,408,000 after buying an additional 679 shares during the last quarter. Aperio Group LLC increased its position in shares of Amsurg Corp. by 9.7% in the first quarter. Aperio Group LLC now owns 7,951 shares of the company’s stock valued at $593,000 after buying an additional 705 shares during the last quarter. Finally, Arizona State Retirement System increased its position in shares of Amsurg Corp. by 4.3% in the first quarter. Arizona State Retirement System now owns 29,360 shares of the company’s stock valued at $2,190,000 after buying an additional 1,200 shares during the last quarter. 98.43% of the stock is owned by institutional investors and hedge funds.
Shares of Amsurg Corp. (NASDAQ:AMSG) traded down 2.17% during mid-day trading on Tuesday, reaching $65.92. The company’s stock had a trading volume of 687,665 shares. Amsurg Corp. has a 1-year low of $58.37 and a 1-year high of $87.29. The company’s 50-day moving average is $65.71 and its 200 day moving average is $73.31. The firm has a market capitalization of $3.54 billion, a P/E ratio of 19.56 and a beta of 0.68.
Amsurg Corp. (NASDAQ:AMSG) last posted its quarterly earnings results on Tuesday, August 2nd. The company reported $1.10 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.08 by $0.02. Amsurg Corp. had a return on equity of 8.20% and a net margin of 6.53%. The firm had revenue of $758.50 million for the quarter, compared to the consensus estimate of $769.88 million. During the same period in the previous year, the business earned $0.97 earnings per share. The company’s revenue for the quarter was up 21.5% compared to the same quarter last year. On average, analysts expect that Amsurg Corp. will post $4.33 earnings per share for the current year.
Several brokerages have recently weighed in on AMSG. Mizuho upped their target price on Amsurg Corp. from $90.00 to $95.00 and gave the stock a “buy” rating in a research note on Friday, June 24th. Bank of America Corp. raised Amsurg Corp. from a “neutral” rating to a “buy” rating and set a $104.00 target price for the company in a research note on Thursday, June 16th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $95.00 target price on shares of Amsurg Corp. in a research note on Thursday, July 14th. Wells Fargo & Co. began coverage on Amsurg Corp. in a research note on Tuesday, June 14th. They set a “market perform” rating for the company. Finally, Zacks Investment Research downgraded Amsurg Corp. from a “buy” rating to a “hold” rating in a research note on Friday, August 5th. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Amsurg Corp. has an average rating of “Buy” and an average price target of $92.09.
In related news, insider Robert Jon Coward sold 7,500 shares of Amsurg Corp. stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $63.65, for a total value of $477,375.00. Following the sale, the insider now directly owns 97,507 shares in the company, valued at $6,206,320.55. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 2.30% of the stock is owned by corporate insiders.
Amsurg Corp. Company Profile
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Want to see what other hedge funds are holding AMSG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amsurg Corp. (NASDAQ:AMSG).
Receive News & Ratings for Amsurg Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amsurg Corp. and related companies with MarketBeat.com's FREE daily email newsletter.